SCHEMBL24933804

SCHEMBL24933804

NC(=O)c1cc(-c2ccc(OCc3ccc(F)nc3)cc2)c(C(F)(F)F)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.39
GRM2 Q14416 1/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HDAC5 Q9UQL6 3/20 0.38
HDAC3 O15379 2/20 0.38
PARP1 P09874 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
BTK Q06187 1/20 0.37
PARP10 Q53GL7 3/20 0.37
CHRM5 P08912 1/20 0.36
DHODH Q02127 1/20 0.35
GSTP1 P09211 1/20 0.34
PPARD Q03181 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30240820 1.00 MAOB (0.39) MAOBGRM2HDAC1HDAC6HDAC5
SCHEMBL24933508 0.90 MRGPRX4 (0.41) MAOBGRM2HDAC1HDAC6HDAC5
SCHEMBL24933815 0.90 NPC1 (0.43) MAOBGRM2HDAC1HDAC6HDAC5
SCHEMBL30240772 0.90 NPC1 (0.43) MAOBGRM2HDAC1HDAC6HDAC5
SCHEMBL24933385 0.88 PARP1 (0.39) MAOBHDAC1HDAC6HDAC5HDAC3
SCHEMBL24933211 0.86 MAOB (0.37) MAOBHDAC1HDAC6HDAC5HDAC3
SCHEMBL24933553 0.86 MAOB (0.46) MAOBHDAC1HDAC6HDAC5HDAC3
SCHEMBL30240692 0.86 MAOB (0.46) MAOBHDAC1HDAC6HDAC5HDAC3
SCHEMBL24933463 0.86 HSD17B1 (0.41) MAOBHDAC1HDAC6HDAC5HDAC3
SCHEMBL24933671 0.86 MAOB (0.56) MAOBPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed